Home » Thermo Scientific Handheld Instruments Chosen for USP Project
Thermo Scientific Handheld Instruments Chosen for USP Project
Thermo Fisher Scientific
Thermo Fisher Scientific announced that the United States Pharmacopeial Convention (USP) has selected its Thermo Scientific TruScan RM and microPHAZIR RX instruments to support its recent initiative to provide USP-approved libraries to pharmaceutical manufacturers.
This spectral library project is one of the many USP initiatives designed to set standards that help ensure the quality, safety and benefit of medicines and foods. With an assembled consortium of world-class vendors, this project aims to provide manufacturers with a USP-approved library of methods for use across the globe for material identification. This provides a harmonized approach to ensuring the quality of pharmaceutical ingredients before entering the supply chain.
"With increases in supply chain variability, the development and deployment of public standards is critical to ensure the safety and efficacy of medicines," said Edward Zhao, vice president, business development of USP. "USP relies on advanced analytical capabilities and modern equipment, such as the TruScan RM and microPHAZIR RX, to provide the highest quality of standards for use by global pharmaceutical manufacturers."
TruScan RM, a Raman-based spectrometer, and microPHAXIR RX, based on near-infrared (NIR), will be used to develop all methods included in the USP spectral library. Both instruments are easy to use and enable on-the-spot, actionable pass-fail results within seconds, the company says.
"We believe it’s important to provide tools to our customers that support their mandates for enhanced product quality and a more secure supply chain," says Maggie Pax, senior director, Pharma-Chem, Thermo Fisher portable analytical instruments. "Our TruScan RM and microPHAZIR RX instruments are perfect complements to the library development project, providing USP with a rapid, easy to use way to develop methods that can be quickly deployed to manufacturers around the world."
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business
Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market
Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online
Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report
CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM
CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding
Biosimilars Market Prediction Up 20 Percent from 2012From Drug Store News
New report forecasts global $2.445 billion market this year
Cholesterol Drugs Could Help Kidney Cancer SurvivalFrom HealthDay News
Study finds statin medications tied to lower death risk after nearly four years of follow-up
Thermo Fisher Scientific Launches Online Configuration ToolFrom Thermo Fisher Scientific
iAutomate software reduces time needed for optimal system set-up design and provides accurate estimates
- All news »